SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...

AI therapy apps promise easy access to mental health care. But convenience comes with hidden costs we're only just beginning ...

ORLANDO, FL / ACCESS Newswire / June 6, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc.

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

Writing for SBM these days is a bit like being in one of those cash grab machines, though instead of money flying over the ...

The AI can analyze a mammogram and catch abnormalities missed by the human eye.

Neil Young once sang of adapting to a world ruled by data and digital minds in “Computer Age.” Today, that vision feels increasingly real as the ...

The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy ...